Shuangcheng Alivia Wu
Biographic Data
| ID | 10914925 |
|---|---|
| NAME | Shuangcheng Alivia Wu |
| GIVEN NAMES | Shuangcheng Alivia |
| FAMILY NAME | Wu |
| SIGNATURE | WU S A |
| AFFILIATIONS | First Affiliated Hospital of Guangzhou University of Chinese Medicine |
| ORCID | 0000-0002-2289-7141 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway
The present study demonstrated that EMO alleviates HFD-induced NAFLD by activating FXR signaling which improves lipid accumulation, insulin resistance, inflammation, and oxidative stress
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor
No prominent works on this page.
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway
The present study demonstrated that EMO alleviates HFD-induced NAFLD by activating FXR signaling which improves lipid accumulation, insulin resistance, inflammation, and oxidative stress
Biochemistry (2 works) · Biology (2 works) · Chemistry (2 works) · Cholesterol (2 works) · Endocrinology (2 works) · Farnesoid X receptor (2 works) · Fatty liver (2 works) · Internal Medicine (2 works) · Lipid metabolism (2 works) · Liver Disease Diagnosis and Treatment (2 works)